LLY

1,017.74

+3%↑

JNJ

194.37

+0.29%↑

ABBV

233.26

+3.63%↑

UNH

339.07

+3.56%↑

AZN

87.67

-1.55%↓

LLY

1,017.74

+3%↑

JNJ

194.37

+0.29%↑

ABBV

233.26

+3.63%↑

UNH

339.07

+3.56%↑

AZN

87.67

-1.55%↓

LLY

1,017.74

+3%↑

JNJ

194.37

+0.29%↑

ABBV

233.26

+3.63%↑

UNH

339.07

+3.56%↑

AZN

87.67

-1.55%↓

LLY

1,017.74

+3%↑

JNJ

194.37

+0.29%↑

ABBV

233.26

+3.63%↑

UNH

339.07

+3.56%↑

AZN

87.67

-1.55%↓

LLY

1,017.74

+3%↑

JNJ

194.37

+0.29%↑

ABBV

233.26

+3.63%↑

UNH

339.07

+3.56%↑

AZN

87.67

-1.55%↓

Search

Myomo Inc

Închisă

0.85

Rezumat

Modificarea prețului

24h

Curent

Minim

0.84

Maxim

0.88

Indicatori cheie

By Trading Economics

Venit

-1.2M

-4.6M

Vânzări

-180K

9.7M

Marjă de profit

-47.989

Angajați

184

EBITDA

-642K

-4.2M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+606.52% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

-31M

33M

Deschiderea anterioară

0.85

Închiderea anterioară

0.85

Myomo Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

11 nov. 2025, 23:59 UTC

Câștiguri

Singtel's 1st Half Net Profit Surges

11 nov. 2025, 22:23 UTC

Achiziții, Fuziuni, Preluări

Mineral Resources Sells Stake in Lithium Mines to Posco For $765 Million

11 nov. 2025, 22:21 UTC

Câștiguri

Aristocrat Boosts Dividend as Annual Profit Rises 12%

11 nov. 2025, 23:52 UTC

Market Talk

Gold Rises Amid Fed Rate-Cut Prospects -- Market Talk

11 nov. 2025, 23:44 UTC

Câștiguri

Singtel's 1H Net Profit Surges

11 nov. 2025, 23:42 UTC

Market Talk

Nikkei May Trade Rangebound Amid Caution over U.S. Econ Strength -- Market Talk

11 nov. 2025, 23:18 UTC

Câștiguri

Singtel: Expects FY Operating Company EBIT to Grow Between High Single Digits and Low Double Digits Vs. Earlier Guidance of High Single-Digit Growth >Z74.SG

11 nov. 2025, 23:15 UTC

Câștiguri

Singtel: Interim Dividend of 8.2 Singapore Cents per Share, up 17% >Z74.SG

11 nov. 2025, 23:14 UTC

Câștiguri

Singtel 1H Underlying Net Profit S$1.35B, Up 14% >Z74.SG

11 nov. 2025, 23:12 UTC

Câștiguri

Singtel 1H Net Exceptional Gain of S$2.05B >Z74.SG

11 nov. 2025, 23:11 UTC

Câștiguri

Singtel 1H Net S$3.40B Vs. Net S$1.23B >Z74.SG

11 nov. 2025, 23:10 UTC

Câștiguri

Singtel 1H Rev S$6.91B Vs. S$6.99B >Z74.SG

11 nov. 2025, 23:04 UTC

Market Talk

RBA Will Sharply Focus On Australian Jobs Report -- Market Talk

11 nov. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

11 nov. 2025, 21:50 UTC

Market Talk
Câștiguri

Health Care Roundup: Market Talk

11 nov. 2025, 21:46 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Private Equity Can Benefit From 'Deal-Friendly' Antitrust Policies -- Market Talk

11 nov. 2025, 21:41 UTC

Câștiguri

Aristocrat: Continues to Actively Pursue Strategic M&A Opportunities

11 nov. 2025, 21:40 UTC

Câștiguri

Aristocrat: Expects to Deliver Npata Growth Over FY 2026 on a Constant Currency Basis

11 nov. 2025, 21:39 UTC

Câștiguri

Aristocrat: Interactive Delivered Revenue Growth Mainly Due to Inclusion of NeoGames

11 nov. 2025, 21:39 UTC

Câștiguri

Aristocrat: Key Social Casino Franchises Continued to Outperform Market

11 nov. 2025, 21:39 UTC

Câștiguri

Aristocrat: Gaming Unit Continued to Deliver Market Share Gains

11 nov. 2025, 21:38 UTC

Câștiguri

Aristocrat: FY Normalized Npata Up 9% in Constant Currency

11 nov. 2025, 21:38 UTC

Câștiguri

Aristocrat: Final Dividend 49 Australian Cents/Share

11 nov. 2025, 21:37 UTC

Câștiguri

Aristocrat: FY Statutory Net Profit from Continuing Ops A$1.18 Bln, Up 2.9%

11 nov. 2025, 21:36 UTC

Câștiguri

Aristocrat: FY Normalized Operating Revenue A$6.3 Bln, Up 11%

11 nov. 2025, 21:35 UTC

Câștiguri

Aristocrat: FY Normalized Npata A$1.55 Bln, Up 12.2%

11 nov. 2025, 21:35 UTC

Câștiguri

Alcon 3Q Adj EPS 79c >ALC

11 nov. 2025, 21:35 UTC

Câștiguri

Alcon 3Q Rev $2.61B >ALC.EB

11 nov. 2025, 21:35 UTC

Câștiguri

Alcon Backs 2025 EPS $3.05-EPS $3.15 >ALC.EB

11 nov. 2025, 21:35 UTC

Câștiguri

Alcon 3Q EPS 48c >ALC.EB

Comparație

Modificare preț

Myomo Inc Așteptări

Obiectiv de preț

By TipRanks

606.52% sus

Prognoză pe 12 luni

Medie 6.5 USD  606.52%

Maxim 10.5 USD

Minim 4 USD

În baza a 4 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruMyomo Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

4 ratings

4

Cumpărare

0

Păstrare

0

Vânzare

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Myomo Inc

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. It also provides the MyoPro 2, including control technology, configuration software and user interface, and pop-out battery for extended use of the brace; and MyoPro2+ that comprises 3D printed orthotics capability, software enhancements, and a design for donning and doffing of the device. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products through various sales channels, including orthotics and prosthetics providers, the Veterans Administration, and its distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
help-icon Live chat